Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Oligodendroglioma × Neoadjuvant Therapy × Clear all

Sponsor

Conditions

Breast Neoplasms 14 Esophageal Neoplasms 5 Adenocarcinoma Of Esophagus 5 Lung Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Sarcoma 3 Rectal Neoplasms 3 Colorectal Neoplasms 3 Carcinoma, Intraductal, Noninfiltrating 3 Squamous Cell Carcinoma of Head and Neck 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Osteosarcoma 2 Multiple Myeloma 2 Kidney Neoplasms 2 Head and Neck Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Carcinoma, Renal Cell 2 Breast Carcinoma In Situ 2 Vomiting 1 Urologic Neoplasms 1 Urogenital Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Teratoma 1 Stomach Neoplasms 1 Sarcoma, Alveolar Soft Part 1 Rhabdomyosarcoma 1 Prostate Adenocarcinoma 1 Ovarian Neoplasms 1

Interventions

Temozolomide 14 Bevacizumab 11 Erlotinib Hydrochloride 5 Radiotherapy 4 Carboplatin 4 Magnetic Resonance Spectroscopy 3 Irinotecan 3 Immunoglobulin G 3 Disulfides 3 temsirolimus 2 poly ICLC 2 palbociclib 2 etoposide phosphate 2 antineoplaston AS 2-1 2 antineoplaston A10 2 Vincristine 2 Sunitinib 2 Sirolimus 2 Everolimus 2 Dasatinib 2 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2 veliparib 1 varlilumab 1 vandetanib 1 trebananib 1 trametinib 1 terameprocol 1 tandutinib 1 selinexor 1 romidepsin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡